Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 19 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
1550P Addressing Uncertainties of Clinical Value and Improving Access for Newly Authorised Indications Through DRUG-Access Protocol (Dap)-Like Platforms: Joint Collection and Evaluation of Real-World Evidence
S.B. van Waalwijk van Doorn-Khosrovani, A.H. Huisman, H.J.L. Timmer,K. Verkerk, F. Verbeek,L. Fagereng, A. Helland,B. Ryll, K. Tasken, K. Jalkanen, J. Oliveira,U.N. Lassen, J-Y. Blay, H. Gelderblom,A. Reyners,F.A. Eskens, E.F. Smit, E.E. Voest, H. Bloemendal
Annals of Oncology (2024)
Cited0Views0Bibtex
0
0
A phase I/II, open label, first-in-human, dose escalation and expansion study of SAR445877 administered as monotherapy in adults with advanced solid tumors
M. Gutierrez,E. Garralda, E. Calvo,M. van Dongen,F. A. Eskens, M. Finlay, F. Z. Menas, C. Zhu, M. Wu, H. Guillemin-Paveau,G. Abbadessa, R. Perez,O. Yildirim,A. Naing
ANNALS OF ONCOLOGY (2023): S646-S647
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 19

#Citation: 371

H-Index: 8

G-Index: 11

Sociability: 5

Diversity: 2

Activity: 2

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn